Dystrophic Epidermolysis Bullosa Clinical Trial
Official title:
A Randomized,Single-Blind, Placebo-controlled, Self-matched Pairing, Independent Evaluated Study to Evaluate the Efficacy and Safety of RGN-137 Topical Gel in Subjects With Junctional and Dystrophic Epidermolysis Bullosa (CELEB)
The objective of this study is to compare the efficacy and safety of RGN-137 topical gel with that of placebo gel for treatment of junctional epidermolysis bullosa (JEB) or dystrophic epidermolysis bullosa (DEB).
RGN-137 will be evaluated for efficacy and safety compared to a Placebo. A matched-pair design will be used to evaluate RGN-137 treatment versus placebo for treatment of 15 subjects with JEB or DEB. Eligible subject must have 1 set of matched-pair wound. The investigator will assign pair of index wounds, each wound with an area between 5cm2 and 50cm2, inclusive, for the eligible subject on Day 1, and for each pair, one wound will be randomized to receive RGN-137 gel and the other to receive Placebo gel. Subjects and independent evaluator will be blinded to the treatment assignments for each wound. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03536143 -
A Phase I/II Study of KB103, a Topical HSV1-COL7, on DEB Patients
|
Phase 1/Phase 2 | |
Recruiting |
NCT04917887 -
Long-Term Follow-up Protocol
|
||
Completed |
NCT04917874 -
A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa
|
Phase 3 | |
Completed |
NCT03472287 -
To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)
|
Phase 1 | |
Recruiting |
NCT05157958 -
Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa
|
Phase 2 | |
Withdrawn |
NCT01528306 -
A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa
|
Phase 2 | |
Completed |
NCT02178969 -
Short Term Observational Study in DEB Patients
|
||
Withdrawn |
NCT04214002 -
The Natural History of Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB)
|
||
Recruiting |
NCT04757727 -
Gynecological Follow-up of Patients With Dystrophic Epidermolysis Bullosa (EBD)
|
||
Withdrawn |
NCT01768026 -
Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa
|
N/A | |
Completed |
NCT01538862 -
Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
|
N/A | |
Completed |
NCT03183934 -
A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial
|
||
Completed |
NCT02579369 -
Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa
|
Phase 1/Phase 2 | |
Withdrawn |
NCT02004600 -
Pilot Study Evaluating the Efficiency and the Tolerance of the PDT in the Treatment of Epidermal Dysplasia for Patients Affected by Hereditary DEB
|
N/A | |
Completed |
NCT04491604 -
Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB
|
Phase 3 | |
Not yet recruiting |
NCT05529134 -
Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04173650 -
MSC EVs in Dystrophic Epidermolysis Bullosa
|
Phase 1/Phase 2 |